Levodopa Pharmacokinetics in Brain after Both Oral and Intravenous Levodopa in One Patient with Advanced Parkinson's Disease
PDF) Continuous levodopa for advanced Parkinson's disease
Review: Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease
Frontiers | Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry
Frontiers | Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry
Concomitant short‐ and long‐duration response to levodopa in the 6‐OHDA‐lesioned rat: a behavioural and molecular study - Marin - 2007 - European Journal of Neuroscience - Wiley Online Library
Recent Advances in the Development of Experimental Therapeutics for Levodopa-Induced Dyskinesia
Lowered cAMP and cGMP signalling in the brain during levodopa‐induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms - Giorgi - 2008 - European Journal of Neuroscience - Wiley Online Library
A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra Pars Compacta in Parkinson's Disease
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap - The Lancet Neurology
Therapeutic strategies for Parkinson's disease: promising agents in early clinical development
Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson's Disease | eNeuro
Frontiers | The Human Experience with Intravenous Levodopa
L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum | Scientific Reports
Impairment of neuronal mitochondrial function by l-DOPA in the absence of oxygen-dependent auto-oxidation and oxidative cell damage | Cell Death Discovery
Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson's Disease | eNeuro
Eltoprazine prevents levodopa-induced dyskinesias by reducing causal interactions for theta oscillations in the dorsolateral striatum and substantia nigra pars reticulate - ScienceDirect
Frontiers | Mathematical Insights into the Effects of Levodopa
PDF) Profile of levodopa/carbidopa intestinal gel and its potential in the treatment of advanced Parkinson's disease
Levodopa Pharmacokinetics in Brain after Both Oral and Intravenous Levodopa in One Patient with Advanced Parkinson's Disease
Evaluation of Levodopa Dose and Magnitude of Dopamine Depletion as Risk Factors for Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease | Journal of Pharmacology and Experimental Therapeutics
Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson's Disease
l‐DOPA‐induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role? - Carta - 2017 - European Journal of Neuroscience - Wiley Online Library
Levodopa-Induced Dyskinesia in Parkinson's Disease
Levodopa Pharmacokinetics in Brain after Both Oral and Intravenous Levodopa in One Patient with Advanced Parkinson's Disease
